SEC Form 4 · accession 0001209191-16-117176
NEOGENOMICS INC · NEO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lynn A. Tetrault
Director
Period of report
Apr 20, 2016
Accepted (ET)
May 3, 2016 · 8:35 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001077183
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Apr 20, 2016 | A | 2,150 | $7.15 | A | 16,710 | D | |
| Common Stock | holding | — | — | — | 14,560 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to buy)F2 | $6.66 | holding | — | — | — | Jul 15, 2016 | Jul 15, 2020 | Common Stock | 0 | 10,000 | D |
Explanation of responses
- F1Lynn Tetrault received 2,150 restricted shares on April 20, 2016 for her service on the board of directors. These shares will vest ratably over each of the next four quarters at 537.5 shares per quarter.
- F2On July 15, 2015, Lynn Tetrault was granted 10,000 stock options. The options vest ratably on the next three anniversary dates of the grant date.